Aav

© GettyImages/BlackJack3D

AskBio and Touchlight restructure JV targeting AAV market

By Jane Byrne

AskBio, a gene therapy company owned and operated as a subsidiary of Bayer AG, and Touchlight, a biotech focused on enzymatic DNA production, have announced a revised structure to their former joint venture, Touchlight AAV.

© GettyImages/AlexanderFord

Ocular gene therapy biotech launches with $19M seed funding

By Jane Byrne

This month sees the launch of a new gene therapy player, Opus Genetics, a company backed and spun out by leading patient group Foundation Fighting Blindness’ venture arm, the Retinal Degeneration Fund (RD Fund).